140 related articles for article (PubMed ID: 16493055)
1. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1.
Kim Y; Lee BD; Kim O; Bae YS; Lee T; Suh PG; Ryu SH
J Immunol; 2006 Mar; 176(5):2969-75. PubMed ID: 16493055
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
El Zein N; Badran B; Sariban E
Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
[TBL] [Abstract][Full Text] [Related]
4. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
El Zein N; Badran B; Sariban E
J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366
[TBL] [Abstract][Full Text] [Related]
5. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
Bae YS; Park JC; He R; Ye RD; Kwak JY; Suh PG; Ho Ryu S
Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human polymorphonuclear leukocytes functions by the neuropeptide pituitary adenylate cyclase-activating polypeptide after activation of MAPKs.
Harfi I; D'Hondt S; Corazza F; Sariban E
J Immunol; 2004 Sep; 173(6):4154-63. PubMed ID: 15356166
[TBL] [Abstract][Full Text] [Related]
7. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists.
Karlsson J; Fu H; Boulay F; Bylund J; Dahlgren C
Biochem Pharmacol; 2006 May; 71(10):1488-96. PubMed ID: 16549058
[TBL] [Abstract][Full Text] [Related]
8. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
9. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling.
Bae YS; Lee HY; Jo EJ; Kim JI; Kang HK; Ye RD; Kwak JY; Ryu SH
J Immunol; 2004 Jul; 173(1):607-14. PubMed ID: 15210823
[TBL] [Abstract][Full Text] [Related]
10. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis.
Lee MS; Ghim J; Kim SJ; Yun YS; Yoo SA; Suh PG; Kim WU; Ryu SH
Cell Signal; 2015 Jul; 27(7):1439-48. PubMed ID: 25862954
[TBL] [Abstract][Full Text] [Related]
12. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I; Tamura H; Hirata M
J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
[TBL] [Abstract][Full Text] [Related]
13. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
[TBL] [Abstract][Full Text] [Related]
14. A novel nonpeptide ligand for formyl peptide receptor-like 1.
Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD
Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762
[TBL] [Abstract][Full Text] [Related]
15. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
Bodart V; Babinski K; Ong H; De Léan A
Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
[TBL] [Abstract][Full Text] [Related]
16. Differential calcium regulation of proinflammatory activities in human neutrophils exposed to the neuropeptide pituitary adenylate cyclase-activating protein.
Harfi I; Corazza F; D'Hondt S; Sariban E
J Immunol; 2005 Sep; 175(6):4091-102. PubMed ID: 16148159
[TBL] [Abstract][Full Text] [Related]
17. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
Tatsuno I; Gottschall PE; Arimura A
Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23.
Miao Z; Premack BA; Wei Z; Wang Y; Gerard C; Showell H; Howard M; Schall TJ; Berahovich R
J Immunol; 2007 Jun; 178(11):7395-404. PubMed ID: 17513790
[TBL] [Abstract][Full Text] [Related]
20. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
Prat C; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2006 Dec; 177(11):8017-26. PubMed ID: 17114475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
